Taken together, the data from this assay support that TRIM56 interacts with cIAP1 via the functional region between amino acids 21–205 (zinc finger domain), thereby inhibiting K48-linked polyubiquitination of cIAP1, reducing cIAP1 degradation and promoting glioma development. The gene discussed is BIRC2; the disease is central nervous system cancer.